Patents
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
05/2006
05/31/2006CN1780827A Process for the manufacture of tocyl and tocopheryl acylates
05/31/2006CN1780825A Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives
05/31/2006CN1780818A Derivados c¿¼clicos fenil-substitu¿¼dos
05/31/2006CN1780619A Derivados de benzoxazol e benzotiazol substitu¿¼dos com (dialopropenil)fenilalquila pesticidas
05/31/2006CN1257899C Fixed bed hydrolysis method for glycoside type soy bean isoflavone materials
05/30/2006US7053117 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
05/30/2006US7053071 Induction of apoptosis in cancer cells
05/26/2006WO2006055694A1 Novel 2h-chromene derivatives as selective estrogen receptor modulators
05/26/2006WO2006054429A1 Oral composition containing difructose anhydride
05/26/2006WO2006053766A1 Methods for purifying trans-(-)-δ9-tetrahydrocannabinol and trans-(+)-δ9-tetrahydrocannabinol
05/26/2006WO2005123077A3 Heteroaryl sulfones and sulfonamides and therapeutic uses thereof
05/26/2006CA2587957A1 Methods for purifying trans-(-)-delta-9-tetrahydrocannabinol and trans-(+)-delta-9-tetrahydrocannabinol
05/26/2006CA2587707A1 Composition containing flavan compound
05/26/2006CA2587669A1 Novel 2h-chromene derivatives as selective estrogen receptor modulators
05/26/2006CA2587040A1 Prodrugs of (2r)-2-propyloctanoic acid for treatment of stroke
05/25/2006US20060111434 Method for preparing derivatives of fungicidal iodochromones
05/25/2006US20060111270 Ketocampholenic acid derivatives and their use in fragrance applications
05/24/2006EP1659119A1 Recovery of isoflavones from soy molasses
05/24/2006EP1659118A1 Recovery of isoflavones from soy molasses
05/24/2006EP1551850B1 2" oxo-voruscharin and derivatives thereof
05/24/2006EP1389619B1 Pkb-3564 substance with neovascularization inhibitory activity
05/24/2006EP1341778B1 Klainetin and derivatives thereof, method for their production and the use of the same
05/24/2006EP1115397B1 Compositions for mitigating the adverse effects of interleukin-2
05/24/2006CN1777614A Substituted benzopyrans as selective estrogen receptor-beta agonists
05/24/2006CN1777577A Antibacterial agents
05/24/2006CN1775772A Use of 3, 4 dihydro-8-hydroxy-1-hydro-2-benzopyran 1 derivative for inhibiting plant pathogenic fungus
05/24/2006CN1775771A Method for extracting natural vitamin E from vegetable oil and fat refining and deodorizing distillate
05/24/2006CN1775759A Bicyclic androgen and progesterone receptor modulator compounds and methods
05/24/2006CN1775712A Method for extracting compounds using folium orthosiphoni leaf and stem as raw material
05/24/2006CN1257164C Aromatic amides, preparation method and application as medicines
05/24/2006CN1257143C Uncatalysed addition reactions
05/23/2006US7049377 1,3-diethers and components and catalysts for the polymerization of olefins, containing said diethers
05/23/2006US7049374 Heterodiamondoids
05/23/2006US7048876 Photochromic compound exhibits absorption bands in two wavelength regions of 440 to 500 nm and 570 to 630 nm.
05/23/2006CA2164863C Polyphenol derivative compositions and preparation thereof
05/18/2006WO2006051378A1 Substituted n-sulfonylaminobenzyl-2-phenoxy acetamide compounds
05/18/2006US20060106234 Obtained by reacting resorcinol and phthalic anhydride in presence of potassium hydrogen sulfate and methyl benzoate ; ophthalmology, for diagnosis, in particular in medical imaging, or in the field of biotechnological applications (for example, as dye to label molecules)
05/18/2006US20060106220 Compositions and therapeutic methods involving isoflavones and analogues thereof
05/18/2006US20060106091 Antigiardial agents and use thereof
05/18/2006US20060106072 Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
05/18/2006US20060105961 Method of using a cox-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia
05/18/2006US20060105412 Phthalein or 9-(o-carboxyphenyl)xanthone compound to which is attached a phenylsulfonyloxy group in which the benzene ring is substituted with an alkyl halide group, a nitro group or a cyano electron-withdrawing group; when the sulfonate bond is cleaved, fluorescein or a derivative is formed
05/18/2006US20060105410 Sulfonate compound and fluorescent probe using the same
05/17/2006EP1657239A2 Chromene compound
05/17/2006EP1656369A1 Novel process for the preparation of 2h-chromenes
05/17/2006EP1656364A1 Chromen-4-one derivatives
05/17/2006EP1088094B1 Biocatalytic process for the preparation of 3-0-acyl-flavonoids
05/17/2006CN1774433A Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists
05/17/2006CN1256308C Yew genus plant extract and its extraction method and application
05/16/2006US7045629 Method for producing-2[-5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane
05/16/2006US7045540 Selective estrogen receptor modulators
05/16/2006US7045514 Therapeutic heterocyclic compounds
05/16/2006CA2192916C Substituted chromanylsulfonyl(thio)ureas, processes for their preparation, their use in pharmaceutical preparations, and pharmaceutical preparations comprising them
05/11/2006WO2006050158A2 Hair and skin protecting compositions based on esters or ethers of betulin
05/11/2006WO2006049234A1 Peroxisome proliferator-activated receptor (ppar) activator and drug, supplement, functional food and food additive using the same
05/11/2006WO2006048122A1 Consumable composition with antioxidants
05/11/2006US20060100252 Beta 3 adrenergic receptor agonists; pollakiuria or urinary incontinence; antiulcer, overactive bladder, pancreatitis, obesity, diabetes, insulin resistance, hypertriglyceridemia, hypercholesterolemia, tocolytic agents; 4'-[2-(2-hydroxy-2-phenylethyl]amino]ethyl]-4-biphenylyl]acetic acid
05/11/2006US20060100238 4',7-Dihydroxyisoflavanone (phenyl)hydrazone; 4,7-Dihydroxyisoflavanone(4,7-dihydroxyisoflavanone)hydrazone; anticarcinogenic and antiinflammatory agents; cyclooxygenase inhibitor
05/11/2006US20060099604 Cysteamine moiety covalently attached to a phthalein, xanthene or naphthalimide dye or a fluorophore, chromophore, magnetic particle, gold particle, or isotopic mass label to form a target-associative tag for analyzing, identifying, or purifying phosphorylated proteins
05/11/2006US20060097248 Can be selectively immobilized as a single molecular layer on a metal electrode, and thus, can be suitably used to manufacture a molecular electronic device comprising an ultra-thin film composed of a single molecular layer; thiol group as an anchoring group introduced into a Rose Bengal molecule
05/10/2006EP1655294A2 Chromene compound
05/10/2006EP1655293A2 Chromene compound
05/10/2006EP1655292A1 Preventive or therapeutic composition for viral infectious disease
05/10/2006EP1653967A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
05/10/2006EP1307189B1 Use of hydroxyethylrutosides for treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
05/10/2006CN1771217A Olivetol-cyclodextrin complexes and regio-selective process for preparing delta 9-tetrahydrocannabinol
05/10/2006CN1769318A Polymeric resin compounds and their preparation
05/10/2006CN1769280A Extraction method of soybean isoflavone from yellow slurry
05/10/2006CN1769279A Method for extracting and separating isoflavone from kudzu slag
05/10/2006CN1769278A Method for extracting and separating isoflavone from kudzu
05/10/2006CN1255396C Carboxylic acid derivatives having fused rings
05/09/2006US7041821 substituted 3-hydroxy-6-oxo-9-phenyl anthracene, acridine, xanthene, or thioxanthene zinc chelating compounds; fluorescent labels for recombinant fusion proteins; nontoxic alternative to nickel based labeling systems; nonreducing environments, cell surfaces
05/09/2006US7041700 Substituted benzopyran derivatives against arrhythmia
05/09/2006US7041354 Optical data carrier comprising a cyanine dye as light-absorbent compound in the information layer
05/09/2006US7041322 Phloridzin-rich phenolic fraction and use thereof as a cosmetic, dietary or nutraceutical agent
05/09/2006CA2233666C Heterocyclic fungicides
05/04/2006WO2006046071A1 Compounds and compositions useful in the treatment of neoplasia
05/04/2006WO2006045495A1 Photochromic h-annellated benzo[f]chrome-derivatives
05/04/2006WO2006023231A3 Fluorescent metal ion indicators with large stokes shift
05/04/2006WO2006002918A3 Use of trisubstituted benzopyranones
05/04/2006WO2005092878A3 Schweinfurthin analogues
05/04/2006US20060094886 Manufacture of tocopheryl acetate
05/04/2006US20060094874 Novel substituted aryl alkenoic acid heterocyclic amides
05/04/2006US20060094776 Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives
05/04/2006US20060094774 Cannabinoid crystalline derivatives and process of cannabinoid purification
05/04/2006US20060093571 Hair and skin protecting compositions based on esters or ethers of betulin
05/04/2006CA2585847A1 Photochromic h-fused benzo[f]chromene derivatives
05/03/2006EP1651628A2 Antibiotic compound
05/03/2006CN1768050A Benzopyran compounds useful for treating inflammatory conditions
05/03/2006CN1765894A Novel flavane derivative and its preparation method and uses
05/02/2006US7038067 Process for synthesizing d-tocotrienols from 2-vinylchromane compound
05/02/2006US7038063 Atropisomers of asymmetric xanthene fluorescent dyes and methods of DNA sequencing and fragment analysis
05/02/2006US7037938 For therapy of urinary incontinence
05/02/2006CA2250426C Amidinohydrazones as protease inhibitors
04/2006
04/27/2006WO2006044293A2 Bicyclic compounds as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
04/27/2006WO2006044176A1 Substituted benzopyrans as selective estrogen receptor-beta agonists
04/27/2006WO2006042454A1 Puerarin derivatives and their medical uses
04/27/2006US20060089404 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
04/27/2006US20060089336 4-Dedimethylamino tetracycline compounds
04/27/2006CA2584507A1 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases